CHRISTY BALLARD: Open Payments
NPI 1679117006 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 57 payments from 27 companies in 2025. Trend: 2023 $861 · 2024 $1,137 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| Merck Sharp & Dohme LLC | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Inspire Medical Systems, Inc. | 2 | $66 |
| Janssen Biotech, Inc. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Immunocore Limited | 2 | $56 |
| BeOne Medicines USA, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Celgene Corporation | 2 | $47 |
Products named: KEYTRUDA, INSPIRE, LIBTAYO, KIMMTRAK, REBLOZYL, KISQALI, SCEMBLIX, CALQUENCE.
Industry payments across AL — which companies pay providers there.
